Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress

BACKGROUND: Metformin is an inhibitor of oxidative phosphorylation that displays an array of anticancer activities. The interference of metformin with the activity of multi-drug resistance systems in cancer cells has been reported. However, the consequences of the acquired chemoresistance for the ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Catapano, Jessica, Luty, Marcin, Wróbel, Tomasz, Pudełek, Maciej, Piwowarczyk, Katarzyna, Kędracka-Krok, Sylwia, Siedlar, Maciej, Madeja, Zbigniew, Czyż, Jarosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673456/
https://www.ncbi.nlm.nih.gov/pubmed/36401206
http://dx.doi.org/10.1186/s11658-022-00400-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673456/
https://www.ncbi.nlm.nih.gov/pubmed/36401206
http://dx.doi.org/10.1186/s11658-022-00400-1

Ejemplares similares